Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Rebeccah Slater at the Pint of Science festival

At this year's event, Professor Rebeccah Slater introduced the audience to researching pain experienced in newborn babies, and the cutting edge methods she is using to understand it.

Pint of Science has become an important part of the Oxford Science calendar.  This year’s Festival ran from the 14- 16th of May - and all the events were fully booked!

‘Understanding Pain’ was held at the Jericho Tavern. Helen Ashdown from Primary Care Health Sciences explained how speed bumps could be used in the diagnosis of, for example, appendicitis. Meanwhile Rebecca Slater from the Paediatric Neuroimaging Research Group discussed her current work using the most up-to-date brain imaging techniques to better understand the development of pain perception in newborn babies.

Timothy Behrens (NDCN) and Chris Summerfield (Exp Psy) took part in ‘How we think and how we do at the Turl Street Kitchen. Tim explained how nature has given us a range of behavioural strategies and how these are generated within our brains. Chris addressed the weighty topic, What does it mean to "think"? A question that has eluded philosophers for thousands of years, and continues to perplex psychologists and neuroscientists.

Pint of Science is a non-profit organisation that brings some of the most brilliant scientists to a local pub to discuss their latest research and findings with you. Founded in 2012/13 it now host events on a global scale including 32 cities across the UK.  It will be back in May 2019.

Similar stories

Oxford University and King’s College London Join IMPACT Network Study to Advance Understanding of Profound Autism

The University of Oxford and King’s College London (King’s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.

University of Oxford launches new public awareness campaign for Neurodevelopmental Disorders

The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.

Breakthrough study moves newborn screening for SMA towards nationwide rollout

A major national study led by researchers in the Department of Paediatrics, to evaluate newborn screening for spinal muscular atrophy (SMA) has been funded by the National Institute for Health and Care Research (NIHR), marking a significant milestone towards the potential introduction of SMA screening across the UK.

Magdalen College lit up for Rare Disease Day

Magdalen College Chapel was lit up in the colours of Rare Disease Day last week, as part of the global Chain of Lights initiative.

World's first Phase II Nipah virus vaccine trial launch

The University of Oxford has launched the world’s first Phase II clinical trial of a Nipah virus vaccine candidate.

Global Consortium Launched to Develop Next-Generation Malaria Vaccine

A new international consortium has been established to advance the development of a next-generation malaria vaccine, that aims to extend the protection against malaria and help lead to future efforts to eliminate it by targeting multiple stages of the parasite’s life-cycle.